Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Oxford Health Clinical Research Facility (OH CRF) is one of 28 facilities across England to benefit from nearly £161 million that has been awarded by the National Institute for Health Research (NIHR) to expand early phase clinical research delivery in NHS hospitals.

Doctor analysing a futuristic hologram of the human brain.

Professor Andrea Cipriani, Director of the Oxford Health NHS FT CRF said: 

 

'We are delighted to have been awarded this prestigious funding by the NIHR for another five years. The funding will enable us to continue to deliver innovative early phase clinical research. It is crucial to have dedicated space and staff for mental health research. We will work in close collaboration with the University of Oxford, Oxford Brookes University and other NHS Trusts, as well as with our many industry partners to test and develop better treatments for patients.'

This is the only dedicated mental health CRF supported by the NIHR. During the pandemic the CRF adapted to support the delivery of two major vaccine trials.

 

Dr Nick Broughton, CEO Oxford Health NHS Foundation Trust said:

 

'It is a great credit to the achievements of the Oxford Health CRF to receive this significant new funding from the NIHR. Research is a key strategic priority for Oxford Health and we're proud to host the CRF and to support its delivery of early translational and experimental medicine research.'

Read more on the NIHR Oxford Health Biomedical Research Centre website.

Similar stories

Unique study of vascular disease reaches 20th anniversary

The only project of its kind anywhere that studies patients with all types of acute vascular events - including strokes, heart attacks, aneurysms - in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.

New funding awarded to study persistent pain in inflammatory arthritis

The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.

Massive Publicity for Study of Effects of Mild COVID on Smell

Researchers from the University of Oxford have used data from UK Biobank participants to look at changes to the brain on average 4.5 months after mild SARS-CoV-2 infection.

Next Radcliffe Department of Medicine Head appointed

Professor Keith Channon has been appointed as the next Head of the Radcliffe Department of Medicine (RDM).

Kia Nobre steps down as Head of Department

Matthew Rushworth replaces Kia Nobre as interim Head of the Department of Experimental Psychology